Aspirin may reduce risk of severe COVID symptoms: Study
Medicina | Free Full-Text | Aspirin Is Related to Worse Clinical Outcomes of COVID-19
Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?
The effects of aspirin on the outcome of COVID-19: A systematic review and meta-analysis - Clinical Epidemiology and Global Health
COVID-19 therapeutics: Challenges and directions for the future | PNAS
Full article: Low-dose aspirin for early COVID-19: does the early bird catch the worm?
Frontiers | Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia - The Lancet Respiratory Medicine
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases
To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial - British Journal of Anaesthesia
Therapeutic advances in COVID-19 | Nature Reviews Nephrology
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation | Nature Reviews Cardiology
Post-acute COVID-19 syndrome | Nature Medicine
Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico - International Journal of Infectious Diseases
Association of mortality and aspirin use for COVID-19 residents at VA Community Living Center Nursing Homes | medRxiv
Could aspirin intake reduce mortality risk in COVID-19 patients?
A guide to immunotherapy for COVID-19 | Nature Medicine
Rapid implementation of mobile technology for real-time epidemiology of COVID-19 | Science
Aspirin & COVID-19 | The International Aspirin Foundation
Biomedicines | Free Full-Text | Aspirin and Infection: A Narrative Review
Use of non-steroidal anti-inflammatory drugs and adverse outcomes during the COVID-19 pandemic: A systematic review and meta-analysis - eClinicalMedicine
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry | Journal of the American Heart Association
Frontiers | Aspirin in COVID-19: Pros and Cons
Pre-hospital Aspirin Use and Patient Outcomes in COVID-19: Results from the International Viral Infection and Respiratory Illness Universal Study (VIRUS) | Archivos de Bronconeumología
Medicina | Free Full-Text | Aspirin Is Related to Worse Clinical Outcomes of COVID-19
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial - The Lancet Respiratory Medicine
Aspirin Use is Associated with Decreased Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis
